A Study of DTC in Patients With AIDS and AIDS Related Complex

Inclusion Criteria

Inclusion Criteria

Concurrent Medication:

Allowed:

- Zidovudine (AZT).

Exclusion Criteria

Co-existing Condition:

Patients with the following are excluded:

- Active opportunistic infection or progressive Kaposi's sarcoma (KS).

- Dementia.

- Lymphoma.

Concurrent Medication:

Excluded within 3 weeks of study entry:

- Other experimental AIDS therapy.

Patients with the following are excluded:

- Active opportunistic infection or progressive Kaposi's sarcoma (KS).

Patients must be either HIV seropositive or have AIDS or AIDS related complex (ARC) and
have life expectancy of at least 6 months.